This trial will assess effects of enrollment in a comprehensive telehealth platform, RecoveryPad (RP), in adults with moderate or severe opioid use disorder.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
470
Telehealth platform to enhance motivation and engagement in treatment for OUD
Yale University
New Haven, Connecticut, United States
RECRUITINGAttendance for MOUD
Overall attendance will be measured by attendance (yes or no) at the first MOUD appointment within 30 days of enrollment.
Time frame: Up to 30 days
Attendance for MOUD
Overall attendance will be measured by attendance (yes or no) at the first MOUD appointment within 31 to 90 days of enrollment.
Time frame: Up to 90 days
Engagement with MOUD
Engagement will be measured by demonstrated maintained attendance with MOUD treatment within 90 days of enrollment.
Time frame: Up to 90 days
Overdose Events at 30 Days
A self-report of the number of subsequent overdose events within 30 days.
Time frame: Up to 30 days
Overdose Events at 90 Days
A self-report of the number of subsequent overdose events within 90 days.
Time frame: Up to 90 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.